5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To determine the impact of high-dose cytarabine (ARA-C) (HDAC) dose modification, based on renal function, on the incidence of neurotoxicity (NT).

          Related collections

          Author and article information

          Journal
          J. Clin. Oncol.
          Journal of clinical oncology : official journal of the American Society of Clinical Oncology
          0732-183X
          0732-183X
          Feb 1997
          : 15
          : 2
          Affiliations
          [1 ] Division of Hematology/Oncology, University of California, San Francisco 94143-0324, USA.
          Article
          10.1200/jco.1997.15.2.833
          9053511
          9bc98286-f279-46b7-bea1-cbcaf15870f5
          History

          Comments

          Comment on this article